Skip to content

Clinical trials on the safety and efficacy of the CRS implant system for dental defect restoration

Clinical trials on the safety and efficacy of the CRS implant system for dental defect restoration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114940
Enrollment
Unknown
Registered
2025-12-19
Start date
2025-12-22
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The loss of dentition or complete edentulism, which may arise from a variety of factors including congenital absence, accidental loss, or periodontal disease.

Interventions

CRS Implant Group:Implant restoration using the CRS Implant System

Sponsors

Stomatological Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Willing to cooperate with the study and having signed the informed consent form; 2.Single tooth missing and being considered for implant restoration; 3.No restriction on gender; age between 18 and 70 years (inclusive); 4.Absence of soft or hard tissue defects or lesions in the implant area that could affect implant placement; 5.Good compliance, willing and able to receive treatment and follow-up observations as required; 6.Clinically and radiographically evaluated as suitable for implantation; 7.The subject must meet the indications for implant restoration of dentition defect or complete edentulism;

Exclusion criteria

Exclusion criteria: 1.Presence of general contraindications for implant treatment or uncontrolled systemic diseases (e.g., diabetes, hypertension, bleeding disorders); 2.Untreated active periodontal disease; 3.Patients with parafunctional habits (e.g., bruxism, clenching); 4.Systemic or local bone diseases (e.g., osteomyelitis of the jaw, bone tuberculosis, bone tumors); 5.History of radiotherapy in the head and neck region; 6.Patients currently receiving or scheduled to undergo radiotherapy/chemotherapy, or taking medications that impair osseointegration; 7.Long-term use or injection of specific medications (e.g., corticosteroids, bisphosphonates); 8.Patients with systemic autoimmune diseases; 9.Neurological disorders (e.g., epilepsy); 10.Psychiatric disorders or psychological impairments; 11.Known allergy to materials used in the dental implant system; 12.Lactating or pregnant women; 13.Other conditions that limit participation, compromise follow-up compliance, or affect scientific integrity of the study; 14.Any other circumstances deemed by the investigator to unsuitable for participation;

Design outcomes

Primary

MeasureTime frame
Implant Success Rate at 1 Year Post-Prosthetic Restoration;

Secondary

MeasureTime frame
Implant Success Rate at 2 Year Post-Prosthetic Restoration;Implant Success Rate at 3 Year Post-Prosthetic Restoration;Alveolar Ridge Resorption;Patient satisfaction;

Countries

China

Contacts

Public ContactJingyi Wu

Stomatological Hospital of Southern Medical University

jingyiwu1121@smu.edu.cn+86 20 84408890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026